Male circumcision for HIV prevention: current research and programmatic issues

Area of Science:

• Public Health
• Infectious Diseases
• Epidemiology

Background:

• Randomized controlled trials in sub-Saharan Africa demonstrate that adult male circumcision reduces HIV acquisition risk by approximately 60% in men.
• Male circumcision is a key intervention in HIV prevention strategies.

Purpose of the Study:

• To review recent data on the association between male circumcision and HIV/sexually transmitted infections (STIs) in both men and women.
• To evaluate the impact of male circumcision on various STIs beyond HIV.

Main Methods:

• Review of recent data from randomized controlled trials and longitudinal studies.
• Analysis of associations between male circumcision and infections including HIV, genital ulcer disease, HSV-2, HPV, Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria gonorrhoea.
• Examination of data concerning men who have sex with men (MSM) and unprotected anal intercourse.

Main Results:

• Male circumcision shows evidence of protection against genital ulcer disease, HSV-2, HPV, and Trichomonas vaginalis, but not Chlamydia trachomatis or Neisseria gonorrhoea in men.
• Longitudinal studies suggest potential long-term benefits for women from male circumcision in HIV-discordant couples.
• Data on protection against HIV acquisition in MSM and those practicing unprotected anal intercourse are inconsistent.
• Limited evidence of increased risky behaviors or adverse sexual function changes.

Conclusions:

• Male circumcision is an effective HIV prevention method for men, with additional benefits against certain STIs.
• Further operational research is needed to optimize the integration and impact of male circumcision services within broader HIV prevention and health system strengthening efforts.
• The review highlights the multifaceted role of male circumcision in sexual health and disease prevention.